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and females had almost similar travel time of 2.43 and 2.40 minutes, respectively 
(p= 0.80). Travel time was 2.44 minutes for the patients younger than 65 years and 
2.28 minutes for patients older than 65 years (p= 0.25). CONCLUSIONS: There was 
no major difference in access to pharmacy based on age or gender. Blacks have 
statistically significantly shorter travel time than whites. Future work will examine 
other factors like socioeconomic status.
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OBJECTIVES: The aim of the analysis was to compare the medicines centrally 
authorised by EMA with reference to their reimbursement in Poland. In Poland, inno-
vative drugs need to be recommended by Agency for Health Technology Assessment 
(AOTM) before the decision about reimbursement is taken by Minister of Health. 
Recommendations issued by AOTM have been based on Manufacturer`s submis-
sion and additional officially published data, including EMA’s data. METHODS: All 
decisions issued by EMA since 1995 connected with new medicines registration 
were analyzed and categorized into therapeutic area. Then it was checked which 
of the drugs found in the EMA’s database were reimbursed in Poland in the years 
2012- 2013. RESULTS: It was found that till the end of December 2014 there were 563 
unique active substance available in EMA’s database. The analysis shows that in 2012 
the reimbursement in Poland was related to 114 active substances registered in EMA, 
which is approx. 20% of all substances in the EMA’s database. A year later 3% (23%) 
more active substances (131) were reimbursed in Poland. Most active substances 
registered in EMA and reimbursed in Poland, belongs to the group ATC: L (antineo-
plastic and immunomodulating medicines). Over 40% of the active ingredients of 
this group registered in EMA were reimbursed in Poland in 2012 and 50% in 2013. 
The second ATC group was A (alimentary tract and metabolism) -12% and group 
B (blood and blood forming organs) -11% (in both years). CONCLUSIONS: Not all 
drugs registered in EMA are reimbursed in Poland. We can conclude that anticancer 
drugs are the most likely to be paid from public sources, then medicines related to 
treatment metabolism and blood disorders. It was found that there was any drug 
reimbursed in Poland registered by EMA in ATC group P (antiparasitic products, 
insecticides and repellents).
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OBJECTIVES: Access to medicines (ATM) is a key component in enabling and meas-
uring the performance of health systems. This study aims to determine, through a 
systematic literature review, the profile of studies and the results of ATM’s indicators 
in Brazil, according with the dimensions of access proposed by Penchansky and 
Thomas METHODS: A systematic review of observational studies was performed 
using articles located in PUBMED, CENTRAL, LILACS and Essential Medicines and 
Health Products Information Portal (WHO) databases (accessed July 2014), in manual 
search and in grey literature. The methodological quality was assessed using the 
Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies of 
NIH (National Institute of Health - USA). RESULTS: 1482 studies were found and 
28 were included. Among these, 64% evaluated access at the municipal level, 75% 
in the public sector, 50% from the perspective of users, 75% the access to essential 
medicines, 50% evaluated more than one dimension, 82% had indicators related 
to availability. Among all dimensions of ATM 18 different indicators were found. 
The indicator with the greatest utilization rate physical availability (PA) was used 
in 39% of the studies. The results of the indicators were variable, ranged from 30 to 
90.2% for PA and from 2.02 to 18.7 for Median Price Ratio, for example. The quality of 
studies included was considered adequate. CONCLUSIONS: Most of ATM studies in 
Brazil evaluated it in the public sector, assessing essential drugs and using as a data 
source the users. The studies had focus on availability and no studies have assessed 
all dimensions of ATM. The access level was variable between studies. This review 
raises the need to develop a guideline to evaluate ATM that foment comparisons 
and evaluations of the health systems performance through the time.
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OBJECTIVES: Accountable Care Organizations (ACOs) are groups of doctors, hos-
pitals, and other health care providers, who come together voluntarily to give 
coordinated high quality care to their Medicare patients. The objective is to under-
stand how the policy development and implementation is helping to solve the cost 
and quality of the fragmented U.S. healthcare system. METHODS: Knovner and 
Knickman (2011) textbook on Healthcare delivery in the United States elaborates 
on the major issues and concerns facing the U.S. healthcare system was used to 
evaluate the policy perspective and CMS published data was used to compare the 
performance of ACOs. RESULTS: ACO was able to deal with all the major issues 
and concerns pointed by Knovner and Knickman(2011) in the policy perspective. 
CMS published data shows that 360 Medicare ACOs has been established serving 
5.6 million Americans. ACOs in Pioneer ACO model and Medicare Shared Savings 
Program (MSSP) generated over $417 million in savings for Medicare. Quality of Care 
and Patient experience showed improvements in 28 of the 33 quality measures and 
30 of 33 quality measures in Pioneer and MSSP ACOs. Only 3 Pioneer ACO and 1 MSSP 
generated shared losses. CONCLUSIONS: The new program has tried to learn from 
strategies to improve the current PP in Pakistan are warranted. Additionally, there 
is a great need of patient educational programs regarding polypharmacy and the 
treatment they receive. Furthermore, additional studies should be undertaken in 
other provinces of Pakistan in order to understand the country level clinicians’ 
prescribing practices.
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OBJECTIVES: This study was aimed to know patients’ awareness and knowledge 
about herbal medicines and their Adverse Drug Reactions (ADRs). METHODS: 322 
patients were asked to give responses to the questionnaire which was developed, 
structured and validated. Random convenience sampling method was used for 
selecting the sample size. The study was conducted in Manipal, Karnataka, India. 
The data was evaluated using SPSS and represented in the form of numbers and per-
centages. RESULTS: 96 patients who have not used herbal medicines were excluded 
from the study. Majority of the patients’ were in the age group of 25-44 (46.3%) 
years and 45-64 (38.8%) years out of which males (54.3%) outnumbered females 
(45.7%). Majority of them were using ayurvedic medicines (24.5%) and combination 
(37%), allopathic and herbal medicines. Reasons behind usage of herbal medicines 
were, more efficacious and lesser side effects (34.07%) and followed by safer than 
conventional drugs (26.54%). Only 39.39% were having knowledge on dose, dura-
tion of therapy, side effects and drug interactions. Main sources of information 
about herbal medicines were found to be friends (32.74%) and drug advertisements 
(32.30%). Of 226 respondents only 65 (28.76%) of them could identify or felt ADRs. 
Out of 65, only 16 of them have reported to physician and 49 patients have taken 
their own decision.18 respondents chosen an alternative therapy, 14 stopped the 
medication, 9 and 8 reduced dosage without consultation and continued medica-
tion respectively. CONCLUSIONS: Overall the respondents of this study were using 
either herbal or combination medicines because they were considered as efficacious 
and have lesser side effects. However, their knowledge related to dose, duration of 
therapy, side effects and drug interaction was less. They were also less aware or 
couldn’t identify ADRs and the ones who were aware about the ADRs, decisions 
taken by them were found to be inappropriate.
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OBJECTIVES: The objective of this study was to evaluate access to healthcare provid-
ers before and after a significant increase in managed care (MC) enrollment in the 
Mississippi Medicaid program. METHODS: A retrospective analysis was conducted 
using Mississippi Medicaid fee-for-service (FFS) and MC pharmacy claims data in the 
period one year prior to (pre-period) and one year after (post-period) the December 
2012 Medicaid MC expansion. Beneficiaries had to be enrolled for at least one month 
during the study period to be included in the analysis. Providers were considered 
to be participating in a plan (FFS or MC) during each observation period if at least 
one pharmacy claim bearing his/her Medicaid provider identity number was filed 
during the period. Distance from beneficiary to provider was calculated by comput-
ing geocodes for their respective zip-codes using the PROC GEOCODE procedure in 
SAS. RESULTS: Overall, the average distance beneficiaries had to travel to see the 
three closest primary care providers (PCPs) or specialists who accept either FFS or 
Medicaid MC plans did not change significantly from the pre- to the post-period (10.2 
miles for PCPs and 7.7 miles for specialist). During the post-period in rural areas, 
beneficiaries in MC had slightly lower distances for PCPs (10.6 miles for MC and 
10.9 for FFS) and for specialist (8.6 miles for MC and 8.9 miles for FFS). Overall, the 
ratio of the number of enrollees per PCP significantly decreased for FFS (p< 0.01) and 
significantly increased for MC plan A and B (p< 0.01). The number of enrollees per 
specialist did not significantly change for FFS (p= 0.059) and significantly increased 
for MC plan A and B (p< 0.01) from the pre- to the post-period. CONCLUSIONS: 
Expansion of Medicaid MC has not adversely affected physician participation in 
Medicaid and in rural areas has slightly improved access to PCPs and specialists.
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OBJECTIVES: It is unknown if timely access to pharmacies differs based on demo-
graphic characteristics. The objective of this study was to determine if disparities 
exist in geographical accessibility to community and hospital pharmacies among 
patients in Hamilton County. METHODS: The Ohio State Board of Pharmacy pro-
vided a list of all the pharmacies in Hamilton County Ohio. The geographic distribu-
tion of the population in each census block group was based on data from Census 
2010. The address of each active pharmacy was geocoded using ArcMap. The loca-
tion of each pharmacy was used to identify the nearest pharmacy to the centroid 
of each census block group. Independent variables included in the study were age, 
gender and race, the dependent variable was travel time to the nearest pharmacy 
from the centroid of each block group. RESULTS: As of November 2014, there were 
173 active community and hospital pharmacies in Hamilton County. Ninety three 
percent of the population had at least one pharmacy within a 5 minute drive time. 
Travel time was 2.57 minutes for whites, 1.96 minutes for blacks (p= 0.0016). Males 
